Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer,.
Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay.